LXEO · NASDAQ · Biotechnology

Lexeo Therapeutics (LXEO)

Develops genetic medicines for inherited cardiovascular disease and select CNS disorders.

$4.07
After hours0.00 (0.00%)
At close$4.07(−0.25%)

Something off on this page? Send us feedback.

Next report
Dec 14, 26
estimated · in 83 days
EPS estimate
−$0.33
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Dec '26
Reported−$0.78−$0.99−$0.60−$0.33−$0.27−$0.25−$0.30Pending
Estimate−$0.87−$0.80−$0.64−$0.48−$0.32−$0.29−$0.29−$0.33
Surprise+10.3%−23.7%+6.3%+31.2%+15.6%+13.8%−5.2%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Dec '26
ReportedPending
Estimate
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2027−$0.34
Sep 2027−$0.35
Jun 2027−$0.35
Mar 2027−$0.35
Dec 2026−$0.34
Dec 2026−$0.33
Aug 2026−$0.29−$0.30−5.2%
May 2026−$0.29−$0.25+13.8%
Mar 2026−$0.32−$0.27+15.6%
Nov 2025−$0.48−$0.33+31.2%
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Sep 2022
Jun 2022
Mar 2022

The latest year is open to everyone — the 15 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2027−$0.34$4.7M
Sep 2027−$0.35$0
Jun 2027−$0.35$0
Mar 2027−$0.35$0
Dec 2026−$0.34$0
Dec 14, 2026−$0.33$0
Aug 12, 2026−$0.29−$0.30−5.2%+1.9%
May 11, 2026−$0.29−$0.25+13.8%+5.0%
Mar 30, 2026−$0.32−$0.27+15.6%−3.5%
Nov 5, 2025−$0.48−$0.33+31.2%−1.8%
Aug 14, 2025
May 12, 2025
Mar 24, 2025
Nov 13, 2024
Aug 12, 2024
May 9, 2024
Mar 11, 2024
Dec 11, 2023
Sep 29, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 30, 2022

The latest year is open to everyone — the 15 quarters behind it read with an account.